This inventor holds 1 USPTO granted patent. Top assignee: Solvay Pharmaceuticals, Gmbh. Active years: 2007.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2007
Title: Unveiling the Innovations of Uwe Schön from Hannover
Introduction: Uwe Schön, a pioneering inventor based in Hannover, Germany, has brought forth a remarkable invention in the field of pharmaceuticals.
Latest Patents: Uwe Schön's notable patent involves Hydronopol derivatives as agonists on human ORL1 receptors, presenting a novel group of compounds with significant pharmacological potential.
Career Highlights: Working at Solvay Pharmaceuticals, Gmbh, Uwe Schön has showcased his expertise in developing compounds targeting ORL1 receptors, paving the way for advancements in the treatment of related disorders.
Collaborations: Alongside dedicated coworkers such as Matthias Mentzel and Dania B Reiche, Uwe Schön has fostered a collaborative environment conducive to innovation and breakthroughs in the pharmaceutical sector.
Conclusion: Uwe Schön’s dedication to innovation and his groundbreaking patent demonstrate his profound impact on the field of pharmaceuticals, underscoring his significance as a notable inventor in Hannover, Germany.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile